Novel foods to treat food allergy and gastrointestinal infection

Current Gastroenterology Reports

Volumn 6, Issue 3, 2004, Pages 254-260

  Perr, Hilary A ^a  

^a CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTHRAX VACCINE; ANTIBIOTIC AGENT; ANTIGEN; BACTERIAL ANTIGEN; CAPSID PROTEIN; ENTEROTOXIN; HELICOBACTER PYLORI VACCINE; IMMUNOGLOBULIN A; PROTEIN; PROTON PUMP INHIBITOR; TYPHOID VACCINE; VACCINE;

ANTHRAX; CLINICAL TRIAL; CROP; DEVELOPING COUNTRY; DRUG DELIVERY SYSTEM; ENVIRONMENTAL FACTOR; FOOD ALLERGY; GASTROINTESTINAL INFECTION; HEALTH CARE COST; HEALTH CARE DELIVERY; HELICOBACTER INFECTION; HUMAN; IMMUNE SYSTEM; IMMUNITY; IMMUNOGENICITY; INFECTION RESISTANCE; INGESTION; INTESTINE MUCOSA; MORBIDITY; MORTALITY; NORWALK GASTROENTERITIS VIRUS; NUTRIENT UPTAKE; NUTRITIONAL INTOLERANCE; NUTRITIONAL VALUE; PROTEIN EXPRESSION; REVIEW; SIDE EFFECT; VACCINATION; AUTOIMMUNITY; CELIAC DISEASE; GASTROINTESTINAL DISEASE; HELICOBACTER PYLORI; IMMUNOLOGY; PEANUT ALLERGY; SOYBEAN; STOMACH MUCOSA; WHEAT; WHEAT ALLERGY;

AUTOIMMUNITY; CELIAC DISEASE; FOOD HYPERSENSITIVITY; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINAL MUCOSA; PEANUT HYPERSENSITIVITY; SOYBEANS; TRITICUM; WHEAT HYPERSENSITIVITY;

EID: 4544365296     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-004-0016-3     Document Type: Review

References (54)

1. Mayer L: Mucosal immunity. Pediatrics 2003, 111: 1595-1600.
2. Kagan RS: Food allergy: an overview. Environ Health Perspect 2003, 111: 223-225.
3. Castro GA, Arntzen CJ: Immunophysiology of the gut: a research frontier for integrative studies of the common mucosal immune system. Am J Physiol 1993, 265: G599-G610.
4. Langridge WHR: Edible vaccines. Sci Am 2000, 283: 66-71.
5. Sicherer SH, Sampson HA, Burks AW: Peanut and soy allergy: a clinical and therapeutic dilemma. Allergy 2000, 55: 515-521.
6. Bannon GA, Shin D, Maleki S, et al.: Tertiary structure and biophysical properties of a major peanut allergen, implications for the production of a hypoallergenic protein. Int Arch Allergy Immunol 1999, 118: 315-316.
7. Rabjohn P, West CM, Connaughton C, et al.: Modification of peanut allergen Ara h 3: effects on IgE binding and T-cell stimulation. Int Arch Allergy Immunol 2002, 128: 15-23.
8. Burks Jr AW, Brooks JR, Sampson HA: Allergenicity of major component proteins of soybean determined by enzyme-linked immunosorbent assay (ELISA) and immunoblotting in children with atopic dermatitis and positive soy challenges. J Allergy Clin Immunol 1988, 81: 1135-1142.
9. Ogawa T, Bando N, Tsuji H et al.: Investigation of the IgE-binding proteins in soybeans by immunoblotting with the sera of the soybean-sensitive patients with atopic dermatitis. J Nutr Sci Vitaminol 1991, 37: 555-565.
10. Herman EM, Helm RM, Jung R, Kinney AJ: Genetic modification removes an immunodominant allergen from soybean. Plant Physiol 2003, 132: 36-43.
11. Suszkiw J: Researchers develop first hypoallergenic soybean. ARS National Program (#302) http://www.nps.ars.usda.gov. Accessed September 2002.
12. Lemaux PG: Advances in technology for cereal breeding. Biotechnology Symposium. UC Davis. http://ucbiotech/talks/crops/advances.html. Accessed August 29, 2000.
13. Matsumoto T: Mitigation of the action of wheat allergen by acidic oxidative potential water. Allergy 2002, 57: 926-930.
14. Harder B: Target: celiac disease. Therapies aimed to complement or replace the gluten-free diet. Science News 2003, 163: 392-393.
15. Buchanan B: Plant research briefing papers: Dr. Bob Buchanan explains how his research using plant biotechnology is removing allergens from existing foods. October 6, 1999 Statement. American Society of Plant Biologists. 2003 http://www.aspb.org/publicaffairs/briefing/buchanan.cfm. Accessed August 15, 2003.
16. Palosuo K: Update on wheat hypersensitivity. Curr Opin Allergy Clin Immunol 2003, 3: 205-209.
17. Sicherer S: Clinical aspects of gastrointestinal food allergy in childhood. Pediatrics 2003, 111: 1609-1616.
18. Palosuo K, Alenius H, Varjonen E, et al.: A novel wheat gliadin as a cause of exercise-induced anaphylaxis. J Allergy Clin Immunol 1999, 103: 912-917.
19. Williamson D, Marsh MN: Celiac disease. Mol Biotechnol 2002, 22: 293-299.
20. Benahmed M, Mention J-J, Matysiak-Budnikk T, et al.: Celiac disease: a future without gluten-free diet? Gastroenterology 2003, 125: 1264-1267.
21. MacDonald WC, Brandborg LL, Flick AI, et al.: Studies of celiac sprue. IV. The response of the whole length of the small bowel to a gluten-free diet. Gastroenterology 1964, 47: 573-589.
22. Celiac disease. NIH Publication No. 03-4269; http://digestive.niddkk.nih.gov/ddiseases/pubs/celiac/index.htm. July 2003. Accessed September 12, 2003.
23. Iughetti L, Bulgarelli S, Forese S, et al.: Endocrine aspects of celiac disease. J Pediatr Endocrinol Metab 2003, 16: 805-818.
24. Battais F, Pineau F, Popineau Y, et al.: Food allergy to wheat: identification of immunoglobulin E and immunoglobulin G-binding proteins with sequential extracts and purified proteins from wheat flour. Clin Exp Allergy 2003, 33: 962-970.
25. Vader LW, Stepniak DT, Bunnik EM, et al.: Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology 2003, 125: 1105-1113.
26. Buchanan BB, Adamidi C, Lozano RM, et al.: Thioredoxin-linked mitigation of allergic responses to wheat. Proc Natl Acad Sci U S A 1997, 94: 5372-5377.
27. Barbeau WE, Novascone A, Elgert KD: Is celiac disease due to molecular mimicry between gliadin peptide-HLA class II molecule-T cell interactions and those of some unidentified superantigen? Mol Immunol 1997, 34: 535-541.
28. Richter L, Kipp PB: Transgenic plants as edible vaccines. Curr Top Microbiol Immunol 1999, 240: 159-176.
29. James C, Krattiger AF: Global Review of the Field Testing and Commercialization of Transgenic Plants, 1986-1995: The First Decade of Crop Biotechnology. Ithaca, NY: ISAAA Briefs; 1996:1.
30. May GD, Afza R, Mason HS, et al.: Generation of transgenic banana (Musa actiminata) plants via Agrobacterium-mediated transformation. BIO TECH 1995, 13: 486-492.
31. Kapusta J, Modelska A, Pniewski T, et al.: Oral immunization of human with transgenic lettuce expressing hepatitis B surface antigen. Adv Exp Med Biol 2001, 495: 299-303.
32. Moffat AS: Crop engineering goes south. Science 1999, 285: 370-371.
33. Clendermen SK, May GD: Differential gene expression in ripening banana fruit. Plant Physiol 1997, 115: 463-469.
34. Washam C: Biotechnology creating edible vaccines. Ann Int Med 1997, 127: 499.
35. Kong Q, Richter L, Yang YF, et al.: Oral immunization with hepatitis B surface antigen expressed in transgenic plants. Proc Natl Acad Sci U S A 2001, 98: 11539-11544.
36. World Health Organization: The World Health Report 1998 executive summary: life in the 21st century: a vision for all. http://www.who.int/whr/2001/archives/1998/index.htm. Accessed April 12, 2002.
37. Black RE, Brown KH, Becker S, et al.: Longitudinal studies of infectious disease and physical growth in rural Bangladesh. II. Incidence of diarrhea and association with known pathogens. Am J Epidemiol 1982, 115: 315-324.
38. Guerrant RL, Kirchhoff LV, Shields DS, et al.: Prospective study of diarrheal illness in Northeastern Brazil: patterns of disease, nutritional impact, etiologies, and risk factors. I Infect Dis 1983, 148: 986-997.
39. Koletzki D, Zankl A, Gelderblom H, et al.: Mosaic hepatitis B virus core particles allow insertion of extended foreign protein segments. J Gen Virol 1997, 70: 2049-2053.
40. Mason HS, Lam DM, Arntzen CJ: Expression of hepatitis B surface antigen in transgenic plants.. Proc Natl Acad Sci U S A 1992, 89: 11745-11749.
41. Tsarev S, Tsareva T, Emerson S, et al.: ELISA for antibody to hepatitis E virus (HEV) based on complete open-ended reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis 1993, 168: 369-378.
42. Ball JM, Hardy MK, Conner ME, et al.: Recombinant Norwalk virus-like particles as an oral vaccine. Arch Virol 1996, 12(Suppl): 243-2491.
43. Crawford SE, Labbe M, Cohen J, et al.: Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J Virol 1994, 68: 5945-5952.
44. Thanavala Y, Yang Y-F, Lyons P, et al.: Immunogenictiy of transgenic plant-derived hepatitis B surface antigen. Proc Natl Acad Sci USA 1995, 92: 3358-3361.
45. Mason HS, Haq TA, Clements ID, et al.: Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT); potatoes expressing a synthetic LT-B gene. Vaccine 1998, 16: 1336-1343.
46. Tacket CO, Mason HS, Lonsonky G, et al.: Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat Med 1998, 4: 607-609.
47. Yu J, Langridge HR: A plant-based multicomponent vaccine protects mice from enteric diseases. Nat Biotechnol 2001, 19: 548-552.
48. Frenck RW Jr, Clemens J: Helicobacter in the developing world. Microbes Infect 2003, 5: 705-713.
49. Svennerholm A-M, Quiding-Jarbrink M: Priming and expression of immune responses in the gastric mucosa. Microbes Infect 2003, 5: 731-739.
50. Svennerholm A-M: Prospects for a mucosally-administered vaccine against Helicobacter pylori. Vaccine 2003, 21: 347-353.
51. Spencer RC; Bacillus anthracis. J Clin Path 2003, 56: 182-186.
52. Aziz MA, Singh S, Kumar PA, et al.: Expression of protective antigen in transgenic plants: a step towards edible vaccine against anthrax. Biochem Biophys Res Commun 2002, 299: 345-351.
53. Sussman H: Spinach makes a safer anthrax vaccine. Drug Discovery Today 2003, 8: 428-430.
54. Pert HA: Children and genetically engineered food: potentials and problems. J Pediatr Gastroenterol Nutr 2002, 35: 475-486.